Primary Prevention of Cardiovascular Disease in Diabetes Mellitus. 2017

Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
Division of Cardiology and the Center for the Prevention of Cardiovascular Disease, Department of Medicine, New York University Medical Center; New York, New York. Electronic address: Jonathan.Newman@nyumc.org.

Type 2 diabetes mellitus (T2D) is a major risk factor for cardiovascular disease (CVD), the most common cause of death in T2D. Yet, <50% of U.S. adults with T2D meet recommended guidelines for CVD prevention. The burden of T2D is increasing: by 2050, approximately 1 in 3 U.S. individuals may have T2D, and patients with T2D will comprise an increasingly large proportion of the CVD population. The authors believe it is imperative that we expand the use of therapies proven to reduce CVD risk in patients with T2D. The authors summarize evidence and guidelines for lifestyle (exercise, nutrition, and weight management) and CVD risk factor (blood pressure, cholesterol and blood lipids, glycemic control, and the use of aspirin) management for the prevention of CVD among patients with T2D. The authors believe appropriate lifestyle and CVD risk factor management has the potential to significantly reduce the burden of CVD among patients with T2D.

UI MeSH Term Description Entries
D009017 Morbidity The proportion of patients with a particular disease during a given year per given unit of population. Morbidities
D011322 Primary Prevention Specific practices for the prevention of disease or mental disorders in susceptible individuals or populations. These include HEALTH PROMOTION, including mental health; protective procedures, such as COMMUNICABLE DISEASE CONTROL; and monitoring and regulation of ENVIRONMENTAL POLLUTANTS. Primary prevention is to be distinguished from SECONDARY PREVENTION and TERTIARY PREVENTION. Prevention, Primary,Disease Prevention, Primary,Prevention, Primordial,Primordial Prevention,Disease Preventions, Primary,Preventions, Primordial,Primary Disease Prevention,Primary Disease Preventions,Primordial Preventions
D002318 Cardiovascular Diseases Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM. Adverse Cardiac Event,Cardiac Events,Major Adverse Cardiac Events,Adverse Cardiac Events,Cardiac Event,Cardiac Event, Adverse,Cardiac Events, Adverse,Cardiovascular Disease,Disease, Cardiovascular,Event, Cardiac
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014943 Global Health A multi- and interdisciplinary field concerned with improving health and achieving equity in health for all people. It transcends national boundaries, promotes cooperation and collaboration within and beyond health science fields, and combines population-based disease prevention with individually-based patient care. International Health Problems,World Health,International Health,Worldwide Health,Health Problem, International,Health Problems, International,Health, Global,Health, International,Health, World,Health, Worldwide,Healths, International,International Health Problem,International Healths,Problem, International Health,Problems, International Health

Related Publications

Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
November 2010, Nature reviews. Endocrinology,
Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
November 2009, Diabetes, obesity & metabolism,
Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
February 2011, Cardiology clinics,
Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
February 2014, Diabetes & metabolism journal,
Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
February 2020, Diabetes research and clinical practice,
Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
May 2015, Medicina clinica,
Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
December 2016, Minerva endocrinologica,
Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
November 2016, Pharmacological research,
Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
January 2021, Archives of medical sciences. Atherosclerotic diseases,
Jonathan D Newman, and Arthur Z Schwartzbard, and Howard S Weintraub, and Ira J Goldberg, and Jeffrey S Berger
August 2023, Deutsche medizinische Wochenschrift (1946),
Copied contents to your clipboard!